Journal list menu
A Message to Our Readers, Authors, and Reviewers
We recognize that the COVID-19 pandemic is affecting everyone’s daily lives and the global research community in unprecedented ways. Although some research activities are slowly resuming, many institutions remain closed, with researchers working from home under unusual circumstances. Our editorial teams also continue to work remotely.
Throughout these challenging times, we aim to support our scientific community in any way possible. Given the possible disruption of experimental work, we kindly ask our reviewers to bear in mind that some experiments may presently be hard to carry out. Now more than ever, it is important to mention clearly which suggestions you consider to be essential. We are aware that authors and reviewers are doing their best to revise and review manuscripts given these circumstances and should you need extra time, please contact the corresponding editorial office without hesitation.
Please accept the best wishes of our editorial teams for your ongoing health and wellbeing.
DOAJ Accepted!
VIEW has now been accepted for indexing in Directory of Open Access Journals (DOAJ)!
DOAJ is a community-curated online directory that indexes and provides access to high quality, open access, peer-reviewed journals.
Announcement
We cordially invite you to submit manuscripts to VIEW. The Article Publication Charge is waived for accepted manuscripts from 2020-2022.
On the Cover
VIEW embraces all significant advances in the research of: Drug delivery, Lab-on-a-chip, Microfluidics, Bioimaging, Bio-markers, Omics, Biosensors and bio-electronics, Computational diagnostics, Bioinformatics, and Novel diagnostic devices, etc.
VIEW publishes full-length research articles, communications, reviews, mini-reviews, perspectives, case reports, analysis and other editorial content of general interest to the field of biomaterials. VIEW aims to be a premier journal for researchers in both academia and industry, providing a platform for transforming research excellence to innovation.
VIEW cordially invites you to submit original research and review articles. All papers will be published online as soon as they are accepted and will be fully citable. In addition, there are no article publication charges for the first three publication years of VIEW.
In article number 20, Ying‐Wei Yang and co‐workers describe metal‐organic framework (MOF)‐based theranostic nanoplatforms that integrate various imaging technologies and treatment strategies have been extensively investigated to improve the diagnosis and treatment of cancer. In this cover, a MOF‐loaded carriage dragged by two horses (one horse represents imaging technologies and the other means treatment strategies) is transported to the castle, symbolizing that MOFs as multifunctional theranostic tools could deliver cargos to the tumor sites for precise cancer therapy guided by various imaging technologies.
In article number 20200034, Pietro Ferraro and co‐workers emphasize that early detection in cancer diseases is a key issue. The current state of the art of technology could allow a great opportunity for this purpose, to develop systems for detecting circulating cancer cells (CTC) in the blood. The challenge is to recognize and classify cancer cells and detect them non‐invasively through a lab‐on‐chip device as they flow. Single‐cell holographic phase contrast tomography offers the possibility in the real world to detect CTC in a label‐free mode by means of morphological analyzes when combined with artificial intelligence (AI). The cover summarizes and depicts the main concepts and the technological ingredients necessary to achieve such an ambitious goal, namely the recognition and sorting of cells, 3D‐imaging by microscope and complete morphological analysis of 3D‐phase‐contrast tomograms by AI tools.
In article number 20200006, Yi‐Tao Long, Yi‐Lun Ying and co‐workers display that aerolysin single‐biomolecule interface is developed to achieve single molecule sensing in a label free manner. To further enhance the sensing performance, sensing regions of Aerolysin nanopore are first determined by the combination of nanopore experiments and molecular dynamics simulation. Aerolysin sensing interface is subsequently designed and tailored at the precision of chemical group via site‐directed mutagenesis. After the well‐designed mutagenesis, electrochemically confined mutant Aerolysin nanopore shows the extremely high selectivity and sensitivity toward target single biomolecules, being further expecting to be widely applied in fast disease diagnosis and protein sequencing.
Articles
-
moreREVIEWOpen access
Advances in surface‐enhanced Raman scattering bioprobes for cancer imaging
- 18 March 2021
Abstract
SERS bioimaging has been successfully employed in cancer screening, diagnosis, and componential analysis in both in vitro and in vivo cancer tissue samples, which simultaneously provides visual morphology and biochemical information. Precise tumor tissue excision, real‐time monitoring of cellular uptake process, and noninvasive cell tracking and labeling are realized due to the effective Raman image bioprobes, satisfying the requirements of precision medicine.
REVIEWOpen accessEmerging optofluidic technologies for biodiagnostic applications
- 14 March 2021
Abstract
Due to its extraordinary functions in fluidic control and signal detection, optofluidic technology has shown great potential in the development of biodiagnostic applications. This paper summarizes the emerging optofluidic technologies in this direction, focusing on three common types of biomarkers: nucleic acid, protein, and cell.
REVIEWOpen accessNano‐therapeutic strategies to target coronavirus
- 9 March 2021
Abstract
The role of nanotechnology in the detection and the therapeutics of the COVID‐19. The image was created with biorender.com.
MINI‐REVIEWOpen accessAlgae: A natural active material for biomedical applications
- 23 February 2021
Abstract
Biomaterials are widely used in biomedical field due to their low toxicity, among which microalgae, as a natural material, have begun to attract great attention. The work of Zhong et al systematically summarized the characteristics and classification of microalgae and emphatically introduced the biomedical application research based on microalgae in recent years.
RESEARCH ARTICLEOpen accessOn‐demand field shaping for enhanced magnetic resonance imaging using an ultrathin reconfigurable metasurface
- 21 February 2021
Abstract
A reconfigurable metasurface is designed to enhance the signal‐to‐noise ratio (SNR) of magnetic resonance imaging (MRI). The metasurface is turned to be off‐resonance during the excitation phase and on‐resonance during the reception phase. The receiving signal from the target region is selective enhanced while the spin‐excitation is minimally disrupted by the metasurface. The brain tumor MR image is reproduced with permission.19
-
The following is a list of the most cited articles based on citations published in the last three years, according to CrossRef.
moreOpen accessApplication of nanotechnology for enhancing photodynamic therapy via ameliorating, neglecting, or exploiting tumor hypoxia
- 23 March 2020
Abstract
A comprehensive review is presented on the recent progress of nanomedicine‐based strategies on intervening with tumor hypoxia for enhancing PDT efficacy. The strategies are based on three different starting point, ameliorating, neglecting, or exploiting tumor hypoxia, for a common purpose: improving PDT efficacy.
Open accessProof‐of‐concept modular fluid handling prototype integrated with microfluidic biochemical assay modules for point‐of‐care testing
- 23 March 2020
Abstract
The palm‐sized device is an integrated, completely sealed, and disposable point‐of‐care testing prototype that exploits the benefits of microfluidics and 3D‐printing fabrication techniques. It consists of a manually operated fluid handling device that allows precise mixing, filtration, and delivery of fluids to an on‐board microfluidic assay unit for subsequent detection of specific biochemical analytes, with minimal risks of contamination.
Open accessPromising methods for detection of novel coronavirus SARS‐CoV‐2
- 23 March 2020
Abstract
The development of antibody‐based immunoassay or nucleic acid testing for detection of SARS‐CoV‐2 infection has become critical for COVID‐19 outbreak control. We introduced the principles of these methods, discussed the scope and practicability of application of the available products and methods, and highlighted the potential approaches to develop additional products and techniques for early diagnosis of COVID‐19.
Open accessMetal‐organic framework‐based cancer theranostic nanoplatforms
- 26 May 2020
Abstract
The advanced achievements of MOFs as theranostic platforms for effective cancer diagnosis and treatment guided by monomodal imaging technologies, including OI, MRI, CT imaging, PET imaging, and PA imaging, and multimodal imaging technologies are summarized, and the development prospects and critical challenges of MOF‐based theranostic systems are also discussed.
Open accessNanoparticles weaponized with built‐in functions for imaging‐guided cancer therapy
- 20 May 2020
Abstract
Imaging‐guided cancer therapy (IGCT) holds remarkable promise for revolutionizing precision cancer theranostics, while it strongly relies on advanced theranostic agents that are largely constructed on top of nanomaterials. Nanoparticles with built‐in functions, particularly those who can naturally combine novel imaging with versatile phototherapies by converting near‐infrared (NIR) light into heat or radicals, are comprehensively summarized herein.
Recent issues
Latest news
Tools
More from this journal
VIEW is a high-quality, interdisciplinary and rapid-publication journal focused on “Biodiagnostics” in the field of biomaterials, from in vitro to in vivo, small to mega, fundamentals to application with the emphasis on the biomaterials used particularly in biotechnology and medicine.
